Related Experiment Videos
Rationale for the use of conjunctive anticoagulation during thrombolysis
1Cardiovascular Division, SUNY Health Science Center, Syracuse 13210, USA.
Coronary Artery Disease
|July 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
High-sensitivity cardiac troponin T in young, healthy adults undergoing non-cardiac surgery.
British journal of anaesthesia·2018
High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis.
Heart (British Cardiac Society)·2014
Fatty acids and TxA(2) generation, in the absence of platelet-COX-1 activity.
Nutrition, metabolism, and cardiovascular diseases : NMCD·2013
Cardiac troponin T before and after kidney transplantation: determinants and implications for posttransplant survival.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Multicenter analytical evaluation of a high-sensitivity troponin T assay.
Clinica chimica acta; international journal of clinical chemistry·2011
Patient survival after kidney transplantation: relationship to pretransplant cardiac troponin T levels.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
Deconditioning in coronary artery disease: an underrecognized problem with contemporary clinical relevance.
Coronary artery disease·2026
Cost‑effectiveness of first‑line immunotherapy-based combination regimens for advanced renal cell carcinoma in China and the United States.
Human vaccines & immunotherapeutics·2026
CD7 CAR-T cells eliminate chronic myeloid leukemia stem cells specifically and effectively.
Hematology (Amsterdam, Netherlands)·2026
Impact of Immunotherapy Prescribing Restrictions on Time to Systemic Therapy and Outcomes in Metastatic Clear Cell Renal Carcinoma in Australia.
Asia-Pacific journal of clinical oncology·2026